Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non...

Por Shimizu, Toshio, Yonesaka, Kimio, Hayashi, Hidetoshi, Iwasa, Tsutomu, Haratani, Koji, Yamada, Hironori, Ohwada, Shoichi, Kamiyama, Emi, Nakagawa, Kazuhiko
Publicado no Cancer Chemother Pharmacol (2017)

Synthetic “smart gel” provides glucose-responsive insulin delivery in diabetic mice

Por Matsumoto, Akira, Tanaka, Miyako, Matsumoto, Hiroko, Ochi, Kozue, Moro-oka, Yuki, Kuwata, Hirohito, Yamada, Hironori, Shirakawa, Ibuki, Miyazawa, Taiki, Ishii, Hitoshi, Kataoka, Kazunori, Ogawa, Yoshihiro, Miyahara, Yuji, Suganami, Takayoshi
Publicado no Sci Adv (2017)